相似文献
1
Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals.
World J Gastroenterol. 2006 Jul 21;12(27):4359-63. doi: 10.3748/wjg.v12.i27.4359.
2
Inhibitory effect of osthole on alcohol-induced fatty liver in mice.
Dig Liver Dis. 2009 Feb;41(2):127-33. doi: 10.1016/j.dld.2008.01.011. Epub 2008 Mar 12.
3
Osthole improves alcohol-induced fatty liver in mice by reduction of hepatic oxidative stress.
Phytother Res. 2011 May;25(5):638-43. doi: 10.1002/ptr.3315. Epub 2010 Oct 27.
4
Therapeutic effect of osthole on hyperlipidemic fatty liver in rats.
Acta Pharmacol Sin. 2007 Mar;28(3):398-403. doi: 10.1111/j.1745-7254.2007.00533.x.
5
Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression.
Planta Med. 2007 Jul;73(8):718-24. doi: 10.1055/s-2007-981552. Epub 2007 Jul 5.
6
Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
Planta Med. 2011 Feb;77(3):231-5. doi: 10.1055/s-0030-1250268. Epub 2010 Aug 17.
7
[Effect of Ganoderma lucidum polysaccharides on oxidative stress of hyperlipidemic fatty liver in rats].
Zhongguo Zhong Yao Za Zhi. 2012 Oct;37(20):3102-6.
8
Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Arch Pharm Res. 2012 Jul;35(7):1241-50. doi: 10.1007/s12272-012-0715-5. Epub 2012 Aug 3.
9
Protective effects of diosgenin in the hyperlipidemic rat model and in human vascular endothelial cells against hydrogen peroxide-induced apoptosis.
Chem Biol Interact. 2010 Mar 30;184(3):366-75. doi: 10.1016/j.cbi.2010.02.005. Epub 2010 Feb 10.
10
Effect of Cydonia oblonga Mill. leaf extract on serum lipids and liver function in a rat model of hyperlipidaemia.
J Ethnopharmacol. 2014 Feb 3;151(2):970-4. doi: 10.1016/j.jep.2013.12.010. Epub 2013 Dec 14.
引用本文的文献
1
Exploring the Toxicity and Therapeutic Potential of and in Zebrafish Larvae: Insights into Anxiety Treatment Mechanisms.
Int J Mol Sci. 2025 Mar 22;26(7):2884. doi: 10.3390/ijms26072884.
2
The Effect of Osthole on Transient Receptor Potential Channels: A Possible Alternative Therapy for Atopic Dermatitis.
J Inflamm Res. 2024 Feb 9;17:881-898. doi: 10.2147/JIR.S425978. eCollection 2024.
3
Osthole Regulates Secretion of Pro-Inflammatory Cytokines and Expression of and in Normal Human Keratinocytes and Fibroblasts.
J Inflamm Res. 2022 Mar 1;15:1501-1519. doi: 10.2147/JIR.S349216. eCollection 2022.
4
Effects of Osthole on Inflammatory Gene Expression and Cytokine Secretion in Histamine-Induced Inflammation in the Caco-2 Cell Line.
Int J Mol Sci. 2021 Dec 20;22(24):13634. doi: 10.3390/ijms222413634.
5
Osthole: A Coumarin Derivative Assuage Thiram-Induced Tibial Dyschondroplasia by Regulating and Expressions in Chickens.
Antioxidants (Basel). 2019 Aug 22;8(9):330. doi: 10.3390/antiox8090330.
6
Application of Metabolomics in the Study of Natural Products.
Nat Prod Bioprospect. 2018 Aug;8(4):321-334. doi: 10.1007/s13659-018-0175-9. Epub 2018 Jun 29.
7
Metabolic map of osthole and its effect on lipids.
Xenobiotica. 2018 Mar;48(3):285-299. doi: 10.1080/00498254.2017.1306660. Epub 2017 Apr 3.
8
PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats.
Inflammopharmacology. 2018 Apr;26(2):425-433. doi: 10.1007/s10787-017-0327-2. Epub 2017 Feb 25.
9
Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding.
J Microbiol. 2015 Dec;53(12):856-63. doi: 10.1007/s12275-015-5239-5. Epub 2015 Dec 2.
10
Osthole: A Review on Its Bioactivities, Pharmacological Properties, and Potential as Alternative Medicine.
Evid Based Complement Alternat Med. 2015;2015:919616. doi: 10.1155/2015/919616. Epub 2015 Jul 13.
本文引用的文献
1
Nonalcoholic fatty liver disease in developing countries.
World J Gastroenterol. 2005 Jun 28;11(24):3808-9. doi: 10.3748/wjg.v11.i24.3808.
2
Nonalcoholic fatty liver disease: a review of current understanding and future impact.
Clin Gastroenterol Hepatol. 2004 Dec;2(12):1048-58. doi: 10.1016/s1542-3565(04)00440-9.
3
Clinical features and risk factors of patients with fatty liver in Guangzhou area.
World J Gastroenterol. 2004 Mar 15;10(6):899-902. doi: 10.3748/wjg.v10.i6.899.
4
Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.
QJM. 2003 Oct;96(10):699-709. doi: 10.1093/qjmed/hcg120.
5
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.
Hepatology. 2003 May;37(5):1202-19. doi: 10.1053/jhep.2003.50193.
6
AGA technical review on nonalcoholic fatty liver disease.
Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572.
7
Non-alcoholic fatty liver disease.
J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S186-90. doi: 10.1046/j.1440-1746.17.s1.10.x.
8
Nonalcoholic steatohepatitis.
Gastroenterology. 2001 Sep;121(3):710-23. doi: 10.1053/gast.2001.27126.
9
Alcoholic liver disease.
Postgrad Med J. 2000 May;76(895):280-6. doi: 10.1136/pmj.76.895.280.
10
Prevalence of and risk factors for hepatic steatosis in Northern Italy.
Ann Intern Med. 2000 Jan 18;132(2):112-7. doi: 10.7326/0003-4819-132-2-200001180-00004.
Zotero 插件